These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 30763657

  • 1. Suppressing pro-inflammatory prostaglandin signaling attenuates excitotoxicity-associated neuronal inflammation and injury.
    Jiang J, Yu Y, Kinjo ER, Du Y, Nguyen HP, Dingledine R.
    Neuropharmacology; 2019 May 01; 149():149-160. PubMed ID: 30763657
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation.
    Jiang J, Quan Y, Ganesh T, Pouliot WA, Dudek FE, Dingledine R.
    Proc Natl Acad Sci U S A; 2013 Feb 26; 110(9):3591-6. PubMed ID: 23401547
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J, Yang MS, Quan Y, Gueorguieva P, Ganesh T, Dingledine R.
    Neurobiol Dis; 2015 Apr 26; 76():126-136. PubMed ID: 25600211
    [Abstract] [Full Text] [Related]

  • 5. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
    Rojas A, Amaradhi R, Banik A, Jiang C, Abreu-Melon J, Wang S, Dingledine R, Ganesh T.
    Neurotherapeutics; 2021 Apr 26; 18(2):1207-1225. PubMed ID: 33410110
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus.
    Nagib MM, Yu Y, Jiang J.
    Pharmacol Ther; 2020 May 26; 209():107504. PubMed ID: 32088247
    [Abstract] [Full Text] [Related]

  • 8. AH6809 decreases production of inflammatory mediators by PGE2 - EP2 - cAMP signaling pathway in an experimentally induced pure cerebral concussion in rats.
    Li P, Jiang H, Wu H, Wu D, Li H, Yu J, Lai J.
    Brain Res; 2018 Nov 01; 1698():11-28. PubMed ID: 29792868
    [Abstract] [Full Text] [Related]

  • 9. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J, Ganesh T, Du Y, Quan Y, Serrano G, Qui M, Speigel I, Rojas A, Lelutiu N, Dingledine R.
    Proc Natl Acad Sci U S A; 2012 Feb 21; 109(8):3149-54. PubMed ID: 22323596
    [Abstract] [Full Text] [Related]

  • 10. A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition.
    Rojas A, Ganesh T, Wang W, Wang J, Dingledine R.
    Neurobiol Dis; 2020 Jan 21; 133():104399. PubMed ID: 30818067
    [Abstract] [Full Text] [Related]

  • 11. Transient inhibition of microsomal prostaglandin E synthase-1 after status epilepticus blunts brain inflammation and is neuroprotective.
    Yasmen N, Sluter MN, Li L, Yu Y, Jiang J.
    Mol Brain; 2023 Jan 25; 16(1):14. PubMed ID: 36694204
    [Abstract] [Full Text] [Related]

  • 12. PGE2 signaling via the neuronal EP2 receptor increases injury in a model of cerebral ischemia.
    Liu Q, Liang X, Wang Q, Wilson EN, Lam R, Wang J, Kong W, Tsai C, Pan T, Larkin PB, Shamloo M, Andreasson KI.
    Proc Natl Acad Sci U S A; 2019 May 14; 116(20):10019-10024. PubMed ID: 31036664
    [Abstract] [Full Text] [Related]

  • 13. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
    Varvel NH, Espinosa-Garcia C, Hunter-Chang S, Chen D, Biegel A, Hsieh A, Blackmer-Raynolds L, Ganesh T, Dingledine R.
    J Neurosci; 2021 Feb 03; 41(5):1105-1117. PubMed ID: 33293358
    [Abstract] [Full Text] [Related]

  • 14. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.
    Yu Y, Li L, Nguyen DT, Mustafa SM, Moore BM, Jiang J.
    Mol Neurobiol; 2020 Jun 03; 57(6):2830-2845. PubMed ID: 32378121
    [Abstract] [Full Text] [Related]

  • 15. Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury.
    Li L, Yu Y, Hou R, Hao J, Jiang J.
    ACS Pharmacol Transl Sci; 2020 Aug 14; 3(4):635-643. PubMed ID: 32832866
    [Abstract] [Full Text] [Related]

  • 16. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
    Engel T, Gomez-Villafuertes R, Tanaka K, Mesuret G, Sanz-Rodriguez A, Garcia-Huerta P, Miras-Portugal MT, Henshall DC, Diaz-Hernandez M.
    FASEB J; 2012 Apr 14; 26(4):1616-28. PubMed ID: 22198387
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
    Kang X, Qiu J, Li Q, Bell KA, Du Y, Jung DW, Lee JY, Hao J, Jiang J.
    Sci Rep; 2017 Aug 25; 7(1):9459. PubMed ID: 28842681
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.